FDA Approved: PALIPERIDONE — Supplemental Application (Tris Pharma Inc)

View source ↗

Summary

FDA granted a supplemental approval for a generic paliperidone product from Tris Pharma Inc (ANDA 212807).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• PALIPERIDONE (paliperidone)

Snippet

SUPPL AP for PALIPERIDONE (PALIPERIDONE)